Ontogeny and regulation of the serotonin transporter: Providing insights into human disorders
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Serotonin (5-hydroxytryptamine, 5-HT) was one of the first neurotransmitters for which a role in development was identified. Pharmacological and gene knockout studies have revealed a critical role for 5-HT in numerous processes, including cell division, neuronal migration, differentiation and synaptogenesis. An excess in brain 5-HT appears to be mechanistically linked to abnormal brain development, which in turn is associated with neurological disorders. Ambient levels of 5-HT are controlled by a vast orchestra of proteins, including a multiplicity of pre- and post-synaptic 5-HT receptors, heteroreceptors, enzymes and transporters. The 5-HT transporter (SERT, 5-HTT) is arguably the most powerful regulator of ambient extracellular 5-HT. SERT is the high-affinity uptake mechanism for 5-HT and exerts tight control over the strength and duration of serotonergic neurotransmission. Perturbation of its expression level or function has been implicated in many diseases, prominent among them are psychiatric disorders. This review synthesizes existing information on the ontogeny of SERT during embryonic and early postnatal development though adolescence, along with factors that influence its expression and function during these critical developmental windows. We integrate this knowledge to emphasize how inappropriate SERT expression or its dysregulation may be linked to the pathophysiology of psychiatric, cardiovascular and gastrointestinal diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lesch, K.-P., Bengel, D., Heils, A., Sabol, S. Z., Greenberg, B. D., Petri, S., Benjamin, J., Müller, C. R., Hamer, D. H., & Murphy, D. L. (1996) · Science · doi:10.1126/science.274.5292.1527 · Cited by 5,162
CpG-rich islands and the function of DNA methylation
Bird, A. P. (1986) · Nature · doi:10.1038/321209a0 · Cited by 3,777 · cited 2×
“Cytosine-phosphate-guanosine (CpG) islands are regionsof thegenomerich in cytosineandguanine(CG)nucleotides and often located in or near promoter regions (Bird, 1986).”
BackgroundRice, D., & Barone, S. (2000) · Environmental Health Perspectives · doi:10.1289/ehp.00108s3511 · Cited by 2,944
Allelic Variation of Human Serotonin Transporter Gene Expression
Heils, A., Teufel, A., Petri, S., Stöber, G., Riederer, P., Bengel, D., & Lesch, K. P. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66062621.x · Cited by 2,221
Valvular heart disease associated with fenfluramine-phentermine
Connolly, H. M., Crary, J. L., McGoon, M. D., Hensrud, D. D., Edwards, B. S., Edwards, W. D., & Schaff, H. V. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708283370901 · Cited by 1,632 · cited 2×
““Fenfen” was found to produce heart valve disease via a 5-HT-induced fibrotic reaction, in which collagen fiber overgrowth, coats and thickens the heart valves leading to cardiac malfunction from valve leakage and regurgitation (Connolly et al., 1997; Gardin et al., 2000; Jick 2000; Soler-Soler and Galve, 2000).”
BackgroundAutism genome-wide copy number variation reveals ubiquitin and neuronal genes
Glessner, J. T., Wang, K., Cai, G., Korvatska, O., Kim, C. E., Wood, S., Zhang, H., Estes, A., Brune, C. W., Bradfield, J. P., et al. (2009) · Nature · doi:10.1038/nature07953 · Cited by 1,421 · cited 1×
“…genes such as Deleted in schizophrenia 1 (Disc1) (Kilpinen et al., 2008), cell adhesion molecules (Wang et al., 2009), copy number variants for cell degradation markers (Glessner et al. 2009), the kinase pathway regulator PTEN (Varga et al., 2009), and the Fragile X FMR gene (Moy et al., 2009).”
BackgroundCaspi, A., Hariri, A. R., Holmes, A., Uher, R., & Moffitt, T. E. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09101452 · Cited by 1,346
Gilstrap, L. C. (1995) · JAMA · doi:10.1001/jama.1995.03520290065031 · Cited by 1,269 · cited 1×
“Dexamethasome is a synthetic glucocorticoid with a wide array of therapeutic uses, including treatment for preterm labor occurring between the 24th and 34th weeks of gestation (Gilstrap et al., 1995).”
BackgroundMood disorders in children and adolescents: an epidemiologic perspective
Kessler, R. C., Avenevoli, S., & Ries Merikangas, K. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01129-5 · Cited by 1,181
Common genetic variants on 5p14.1 associate with autism spectrum disorders
Wang, K., Zhang, H., Ma, D., Bucan, M., Glessner, J. T., Abrahams, B. S., Salyakina, D., Imielinski, M., Bradfield, J. P., Sleiman, P. M. A., et al. (2009) · Nature · doi:10.1038/nature07999 · Cited by 989 · cited 1×
“…but are not limited to, scaffolding protein genes such as Deleted in schizophrenia 1 (Disc1) (Kilpinen et al., 2008), cell adhesion molecules (Wang et al., 2009), copy number variants for cell degradation markers (Glessner et al. 2009), the kinase pathway regulator PTEN (Varga et al., 2009),…”
BackgroundPten Regulates Neuronal Arborization and Social Interaction in Mice
Kwon, C.-H., Luikart, B. W., Powell, C. M., Zhou, J., Matheny, S. A., Zhang, W., Li, Y., Baker, S. J., & Parada, L. F. (2006) · Neuron · doi:10.1016/j.neuron.2006.03.023 · Cited by 970
Early-Life Blockade of the 5-HT Transporter Alters Emotional Behavior in Adult Mice
Ansorge, M. S., Zhou, M., Lira, A., Hen, R., & Gingrich, J. A. (2004) · Science · doi:10.1126/science.1101678 · Cited by 817 · cited 2×
“…either by administration of SSRIs to pregnant dams or directly to pups early postnatally, has receivedmuch attention (Hilakivi et al., 1986; Yannielli et al., 1999; Ansorge et al., 2004, 2008; Forcelli & Heinrichs, 2008; Popa et al., 2008; and see Table 2 for review in Narboux-Nême et al., 2008).”
BackgroundAutism‐like behavioral phenotypes in BTBR T+tf/J mice
McFarlane, H. G., Kusek, G. K., Yang, M., Phoenix, J. L., Bolivar, V. J., & Crawley, J. N. (2008) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2007.00330.x · Cited by 812 · cited 2×
“Some of these dual polymorphisms have been replicated in inbred and/or transgenic mice and result in altered brain morphology and/or socially impairedphenotypes reminiscent of autism(Kwonet al., 2006; McFarlane et al., 2008; Moy et al., 2008; Page et al., 2009; Ayhan et al., 2010).”
BackgroundHigh cholesterol level is essential for myelin membrane growth
Saher, G., Brügger, B., Lappe-Siefke, C., Möbius, W., Tozawa, R.-I., Wehr, M. C., Wieland, F., Ishibashi, S., & Nave, K.-A. (2005) · Nature Neuroscience · doi:10.1038/nn1426 · Cited by 799 · cited 2×
“, 2008), or cholesterol composition in lipid microdomains or “rafts” that regulate intracellular turnover and transport of SERT (Magnani et al., 2004; Saher et al., 2005) could alter SERT surface availability and the balance of extracellular and intracellular 5-HT levels.”
BackgroundPrenatal stress, glucocorticoids and the programming of adult disease
Cottrell, E. C. (2009) · Frontiers in Behavioral Neuroscience · doi:10.3389/neuro.08.019.2009 · Cited by 640 · cited 1×
“…to under nutrition a wide variety of stressors (or activators of theHPA axis) during early preand postnatal development exert profound effects on the 5-HT system and SERTexpression,whichmaybe linked to altered brain structure and wiring (Calabrese et al., 2009; Cottrell & Seckl, 2009; McEwen 2010).”
BackgroundMann, J. J., Huang, Y.-Y., Underwood, M. D., Kassir, S. A., Oppenheim, S., Kelly, T. M., Dwork, A. J., & Arango, V. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.8.729 · Cited by 613 · cited 1×
“Binding studies in post-mortem tissue have also failed to identify variation in SERT expression among 5-HTTLPR genotypes (Mann et al., 2000; Arango et al., 2003).”
BackgroundZhu, C.-B., Blakely, R. D., & Hewlett, W. A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301029 · Cited by 549 · cited 1×
“Zhu et al. (2006) went on to show, using raphe neuron derived RN46A cells, that both IL-1β and TNF-α cause rapid catalytic activation of SERT, which was p38 MAPK dependent.”
BackgroundSlotkin, T. A. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2003.06.001 · Cited by 544 · cited 1×
“Its effects on various neurotransmitter systems have beenwidely studied (Ernst et al., 2001; Slotkin 2004, 2008; Slotkin et al., 2007a, 2007b; Dwyer et al., 2008; Herrmann et al., 2008; Pauly & Slotkin, 2008), but less is known about its direct effects on SERT.”
BackgroundSerretti, A., Kato, M., De Ronchi, D., & Kinoshita, T. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001926 · Cited by 529
Targeting the murine serotonin transporter: insights into human neurobiology
Murphy, D. L., & Lesch, K.-P. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2284 · Cited by 478 · cited 3×
“As reviewed by Murphy and Lesch (2008), expression of SERT as a function of 5-HTTLPR genotype can be further modified by the co-existence of SNPs, some of whichwere described earlier.”
BackgroundMethodA trans-dimensional approach to the behavioral aspects of depression
Bessa, J. M. (2009) · Frontiers in Behavioral Neuroscience · doi:10.3389/neuro.08.001.2009 · Cited by 469
Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder
Kato, M., & Serretti, A. (2010) · Molecular Psychiatry · doi:10.1038/mp.2008.116 · Cited by 450 · cited 2×
“Since this time there has been much controversy and debate, with some groups able to replicate this finding and others not (for reviews see Vergne and Nemeroff, 2006; Caspi et al., 2010; Kato and Serretti, 2010).”
BackgroundThe developmental neurobiology of autism spectrum disorder
DiCicco-Bloom, E., Lord, C., Zwaigenbaum, L., Courchesne, E., Dager, S. R., Schmitz, C., Schultz, R. T., Crawley, J., & Young, L. J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1712-06.2006 · Cited by 434 · cited 2×
“…polymorphisms of the SERT appear to be associated with higher risk of developing the disorder, as well as with rigid-compulsive traits, consistent with obsessive–compulsive disorder (Murphy et al., 2004; Devlin et al., 2005; Sutcliffe et al., 2005; DiCicco-Bloom et al., 2006;Moy et al., 2006).”
BackgroundSutcliffe, J. S., Delahanty, R. J., Prasad, H. C., McCauley, J. L., Han, Q., Jiang, L., Li, C., Folstein, S. E., & Blakely, R. D. (2005) · The American Journal of Human Genetics · doi:10.1086/432648 · Cited by 392 · cited 1×
“Indeed, abnormal levels of 5-HT result in aberrant morphology and wiring of the nervous system across species, ranging from Drosophila (Sykes & Condron, 2005; Daubert et al., 2010), to Aplysia (Castellucci et al., 1970; Brunelli et al., 1976) to mammals (see Gaspar et al., 2003 for review).”
BackgroundBarr, C. S., Newman, T. K., Shannon, C., Parker, C., Dvoskin, R. L., Becker, M. L., Schwandt, M., Champoux, M., Lesch, K. P., Goldman, D., et al. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.12.008 · Cited by 385
Brain Serotonin and Dopamine Transporter Bindings in Adults With High-Functioning Autism
Nakamura, K., Sekine, Y., Ouchi, Y., Tsujii, M., Yoshikawa, E., Futatsubashi, M., Tsuchiya, K. J., Sugihara, G., Iwata, Y., Suzuki, K., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.137 · Cited by 352
Serotonin: a regulator of neuronal morphology and circuitry
Daubert, E. A., & Condron, B. G. (2010) · Trends in Neurosciences · doi:10.1016/j.tins.2010.05.005 · Cited by 326 · cited 1×
“…etc.) during brain development, and its perturbationmay adversely alter behavior and future responsiveness to psychoactive drugs (Chandana et al., 2005; Whitaker-Azmitia, 2005; Boylan et al., 2007; Murrin et al., 2007; Carola et al., 2010; Daubert & Condron, 2010; Jones et al., 2010; Mulla, 2010).”
BackgroundNeurochemical correlates of autistic disorder: a review of the literature
Lam, K. S. L., Aman, M. G., & Arnold, L. E. (2006) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2005.03.003 · Cited by 318 · cited 2×
“disorders not otherwise specified (PDD-NOS), with a broad range of symptoms and severity, are complex disorders that are frequently marked by abnormalities in 5-HT metabolism and neurotransmission (Santangelo and Tsatsanis 2005; Lam et al., 2006).”
BackgroundZhu, C.-B., Lindler, K. M., Owens, A. W., Daws, L. C., Blakely, R. D., & Hewlett, W. A. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.116 · Cited by 317
Self-citationRomeo, R. D., Mueller, A., Sisti, H. M., Ogawa, S., McEwen, B. S., & Brake, W. G. (2003) · Hormones and Behavior · doi:10.1016/s0018-506x(03)00063-1 · Cited by 285
Nicotine and brain development
Dwyer, J. B., Broide, R. S., & Leslie, F. M. (2008) · Birth Defects Research Part C: Embryo Today: Reviews · doi:10.1002/bdrc.20118 · Cited by 256 · cited 1×
“Its effects on various neurotransmitter systems have beenwidely studied (Ernst et al., 2001; Slotkin 2004, 2008; Slotkin et al., 2007a, 2007b; Dwyer et al., 2008; Herrmann et al., 2008; Pauly & Slotkin, 2008), but less is known about its direct effects on SERT.”
BackgroundSocial approach in genetically engineered mouse lines relevant to autism
Moy, S. S., Nadler, J. J., Young, N. B., Nonneman, R. J., Grossman, A. W., Murphy, D. L., D’Ercole, A. J., Crawley, J. N., Magnuson, T. R., & Lauder, J. M. (2009) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2008.00452.x · Cited by 246 · cited 2×
“…genes such as Deleted in schizophrenia 1 (Disc1) (Kilpinen et al., 2008), cell adhesion molecules (Wang et al., 2009), copy number variants for cell degradation markers (Glessner et al. 2009), the kinase pathway regulator PTEN (Varga et al., 2009), and the Fragile X FMR gene (Moy et al., 2009).”
BackgroundGenetics of the serotonergic system in suicidal behavior
Arango, V., Huang, Y.-Y., Underwood, M. D., & Mann, J. J. (2003) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(03)00048-7 · Cited by 239 · cited 1×
“Binding studies in post-mortem tissue have also failed to identify variation in SERT expression among 5-HTTLPR genotypes (Mann et al., 2000; Arango et al., 2003).”
BackgroundZhu, C.-B., Carneiro, A. M., Dostmann, W. R., Hewlett, W. A., & Blakely, R. D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410858200 · Cited by 228
Maternal tobacco smoking, nicotine replacement and neurobehavioural development
Pauly, J. R., & Slotkin, T. A. (2008) · Acta Paediatrica · doi:10.1111/j.1651-2227.2008.00852.x · Cited by 214 · cited 1×
“Its effects on various neurotransmitter systems have beenwidely studied (Ernst et al., 2001; Slotkin 2004, 2008; Slotkin et al., 2007a, 2007b; Dwyer et al., 2008; Herrmann et al., 2008; Pauly & Slotkin, 2008), but less is known about its direct effects on SERT.”
BackgroundSlotkin, T. A. (2008) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2007.09.002 · Cited by 206
Wheatcroft, J., Wakelin, D., Smith, A., Mahoney, C. R., Mawe, G., & Spiller, R. (2005) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2005.00719.x · Cited by 205 · cited 2×
“In addition, there is evidence to suggest that inflammation of the gut, via inflammatory mediators including interferon-γ and tumor necrosis factor α, reduces SERT expression and function (Linden et al., 2003, 2005; Wheatcroft et al., 2005; Mawe et al., 2006; Foley et al., 2007).”
BackgroundMoll, G. H., Mehnert, C., Wicker, M., Bock, N., Rothenberger, A., Rüther, E., & Huether, G. (2000) · Developmental Brain Research · doi:10.1016/s0165-3806(99)00182-0 · Cited by 204 · cited 1×
“In the juvenile brain, SERT binding measured using a SERT selective radioligand in homogenates prepared from rodent frontal cortex, increases steadily from weaning until late adulthood (Moll et al., 2000).”
MethodLambe, E. K., Krimer, L. S., & Goldman-Rakic, P. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-23-08780.2000 · Cited by 204 · cited 2×
“…those in non-human primates, where serotonergic axons have been detected in entorhinal cortex in early embryonic life of rhesus macques (Berger et al., 1993) and where the 5-HT terminal network has been shown to mature very rapidly during early postnatal life (Lambe et al., 2000; Verney, 2003).”
BackgroundRole of the serotonin transporter gene in the behavioral expression of autism
Tordjman, S., Gutknecht, L., Carlier, M., Spitz, E., Antoine, C., Slama, F., Carsalade, V, Cohen, D. J., Ferrari, P., Roubertoux, P. L., et al. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000873 · Cited by 196
Ontogeny of fear-, anxiety- and depression-related behavior across adolescence in C57BL/6J mice
HEFNER, K., & HOLMES, A. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.10.001 · Cited by 183 · cited 1×
“In rodents, PD21 is considered juvenile and PD28, early adolescent (Bylund and Reed, 2007; Hefner and Holmes, 2007; Pechnick et al., 2008; Reed et al., 2008).”
BackgroundCarneiro, A. M. D., Cook, E. H., Murphy, D. L., & Blakely, R. D. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33374 · Cited by 180 · cited 3×
“…(e.g. Blakely et al., 1998; Daws et al., 2000; Ansahet al., 2003; Zhuet al., 2004, 2005, 2007), cytokines (e.g. Zhuet al., 2010), integrins (e.g. Carneiro et al., 2008), neurotrophic factors such as BDNF (e.g. Daws et al., 2007) as well as hormones (e.g. Slotkin et al., 1996a, 1996b, 2006;…”
BackgroundInfluentialSerotonin and dopamine transporter binding in children with autism determined by SPECT
Makkonen, I., Riikonen, R., Kokki, H., Airaksinen, M. M., & Kuikka, J. T. (2008) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2008.03027.x · Cited by 169
Stimulants and the developing brain
Andersen, S. L. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.03.009 · Cited by 168 · cited 2×
“…but further drug-induced increases may have the opposite effect, assuming a U-shaped dose–effect curve, which is why psychostimulants such as the amphetamines administered to children with attention deficit hyperactivity disorder (ADHD) can effectively reduce hyperactivity (Andersen, 2005).”
BackgroundRegulation of the Human Serotonin Transporter by Interleukin-1β
Ramamoorthy, S., Ramamoorthy, J. D., Prasad, P. D., Bhat, G. K., Mahesh, V. B., Leibach, F. H., & Ganapathy, V. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2659 · Cited by 156
Epigenetic regulation of serotonin transporter expression and behavior in infant rhesus macaques
Kinnally, E. L., Capitanio, J. P., Leibel, R., Deng, L., LeDuc, C., Haghighi, F., & Mann, J. J. (2010) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2010.00588.x · Cited by 155
Narboux-Nême, N., Pavone, L. M., Avallone, L., Zhuang, X., & Gaspar, P. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.08.020 · Cited by 148 · cited 1×
“For example, in BALB/c and C57BL/6 mice, adult hippocampal neurogenesis only occurred when treatment commenced in adolescence (PD35), and this effect was abolished by stress (Navailles et al., 2008).”
BackgroundAyhan, Y., Abazyan, B., Nomura, J., Kim, R., Ladenheim, B., Krasnova, I. N., Sawa, A., Margolis, R. L., Cadet, J. L., Mori, S., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2009.144 · Cited by 148
The age-dependent effects of selective serotonin reuptake inhibitors in humans and rodents: a review
Olivier, J. D. A., Blom, T., Arentsen, T., & Homberg, J. R. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.09.013 · Cited by 131
Verney, C., Lebrand, C., & Gaspar, P. (2002) · The Anatomical Record · doi:10.1002/ar.10089 · Cited by 119
Expression of serotonin transporter protein in developing rat brain
Zhou, F. C., Sari, Y., & Zhang, J. K. (2000) · Developmental Brain Research · doi:10.1016/s0165-3806(99)00152-2 · Cited by 111 · cited 3×
“…(Lebrand et al., 1996; Hansson et al., 1998, 1999), autoradiographic binding (D'Amato et al., 1987; Bennett-Clarke et al., 1997) and immunocytochemical (Lebrand et al., 1998; Zhou et al., 2000) approaches also reveal transient SERT gene and protein expression in brain during early development.”
BackgroundTuccori, M., Testi, A., Antonioli, L., Fornai, M., Montagnani, S., Ghisu, N., Colucci, R., Corona, T., Blandizzi, C., & Tacca, M. D. (2009) · Clinical Therapeutics · doi:10.1016/j.clinthera.2009.07.009 · Cited by 95
Decreased Cortical Serotonin in Neonatal Rabbits Exposed to Endotoxin in Utero
Kannan, S., Saadani-Makki, F., Balakrishnan, B., Dai, H., Chakraborty, P. K., Janisse, J., Muzik, O., Romero, R., & Chugani, D. C. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.156 · Cited by 58 · cited 1×
“More recently, maternal immune system activation in response to intrauterine infection in rabbit dams was reported to produce decreases in 5-HT immunoreactive fiber expression in the somatosensory cortex, reduced cortical SERT mRNA expression, and decreased 5-HT levels and tryptophan metabolism in 1-day old kits (Kann…”
BackgroundGould, G. G., Javors, M. A., & Frazer, A. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.029 · Cited by 18
Self-citation
Cited by
An atlas of the protein-coding genes in the human, pig, and mouse brain
Sjöstedt, E., Zhong, W., Fagerberg, L., Karlsson, M., Mitsios, N., Adori, C., Oksvold, P., Edfors, F., Limiszewska, A., Hikmet, F., et al. (2020) · Science · doi:10.1126/science.aay5947 · Cited by 1,151
“It has earlier been reported (41) that the expression of this transporter in the human and mouse developing brain is widespread before its expression is restricted to serotonergic neurons in the adult brain.”
BackgroundThe role of maternal obesity in the risk of neuropsychiatric disorders
Rivera, H. M., Christiansen, K. J., & Sullivan, E. L. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00194 · Cited by 307
Perinatal iron deficiency and neurocognitive development
Radlowski, E. C., & Johnson, R. W. (2013) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2013.00585 · Cited by 315
“SERT is expressed more during development than in adulthood (Daws and Gould, 2011).”
BackgroundNeuroinflammation as a risk factor for attention deficit hyperactivity disorder
Dunn, G. A., Nigg, J. T., & Sullivan, E. L. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.05.005 · Cited by 299
“The 5-HT system plays a critical role in brain development, including neurogenesis, neuronal migration and synaptogenesis (Daws and Gould, 2011; Kannan et al., 2011).”
BackgroundMaternal high fat diet consumption during the perinatal period programs offspring behavior
Sullivan, E. L., Nousen, E. K., & Chamlou, K. A. (2014) · Physiology & Behavior · doi:10.1016/j.physbeh.2012.07.014 · Cited by 217
“Numerous aspects of brain development including neuronal migration, neurogenesis, and synaptogenesis are regulated by the serotonin (5-HT) system [109, 110].”
Metadata
- Authors
- Daws, L. C., & Gould, G. G.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2011-07
- Volume
- 131
- Issue
- 1
- Pages
- 61-79
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2011888952
- Cited by
- 116
- References
- 54
- FWCI
- 4.88
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.